Altmetric
A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator's choice in the treatment of patients with relapsed/refractory adult tTcell leukemia-lymphoma: overall response rate, progression-free survival, and overall survival
Publication available at: | https://doi.org/10.1182/blood.V128.22.4159.4159 |
---|
Title: | A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator's choice in the treatment of patients with relapsed/refractory adult tTcell leukemia-lymphoma: overall response rate, progression-free survival, and overall survival |
Authors: | Phillips, A Fields, P Hermine, O Ramos, JC Beltran, BE Pereira, J Brites, C Wandroo, FA Lill, M Feldman, TA Casanova, L Janakiram, M Meniane, J-C Sawas, A Cook, LB Kurman, MR George, J Dwyer, K Leoni, M Conlon, K Taylor, GP Gonsky, J Horwitz, SM |
Item Type: | Conference Paper |
Issue Date: | 2-Dec-2016 |
Date of Acceptance: | 1-Jun-2021 |
URI: | http://hdl.handle.net/10044/1/104890 |
DOI: | 10.1182/blood.V128.22.4159.4159 |
ISSN: | 0006-4971 |
Publisher: | American Society of Hematology |
Start Page: | 4159 |
End Page: | 4159 |
Journal / Book Title: | Blood |
Volume: | 128 |
Issue: | 22 |
Copyright Statement: | © 2016 by The American Society of Hematology |
Conference Name: | 58th ASH Annual Meeting and Exposition |
Publication Status: | Published |
Start Date: | 2016-12-03 |
Finish Date: | 2016-12-06 |
Conference Place: | San Diego, CA |
Open Access location: | https://doi.org/10.1182/blood.V128.22.4159.4159 |
Online Publication Date: | 2021-06-15 |
Appears in Collections: | Department of Immunology and Inflammation Department of Infectious Diseases |